Follow-The-Filings

Security · featured owners

DBVT Dbv Technologies S A Sponsored

Health Care ADS Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $6M

DBVT (Dbv Technologies S A Sponsored) is held in 1 featured 13F book as of 2026 Q2. Stanley Druckenmiller - Duquesne Family Office is the largest tracked holder by portfolio weight (0.12%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Stanley Druckenmiller - Duquesne Family Office) · not free-float ownership

  1. Stanley Druckenmiller 0.12%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.12% Hold 383,363 $6M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-K/A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
424B3 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 8 rows shown

Filed Form Detail Links
4 Period Jul 29, 2026 Filing Doc
4 Period Jan 29, 2026 Filing Doc
4 Period Jan 12, 2026 Filing Doc
4 Period Dec 17, 2025 Filing Doc
4 Period Nov 20, 2025 Filing Doc
4 Period Nov 21, 2025 · 3 forms Filing Doc
4 Period Jul 29, 2025 Filing Doc
4 Period May 22, 2025 Filing Doc

Updated 12 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $15.73M $4.15M $5.64M
Net income -$72.73M $113.92M -$146.95M
Net margin * -462.4% 2744.4% -2607.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $158.92M $44.39M $212.94M
Total non-current assets * $24.07M $21.27M $20.78M
Total assets $182.99M $65.66M $233.72M
Total current liabilities $37.34M $31.14M $58.02M
Total non-current liabilities $5.46M $7.14M $6.92M
Total equity $140.19M $27.39M $168.77M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$79.65M -$104.47M -$121.18M
Cash from investing -$0.808M -$0.757M -$1.37M
Cash from financing $6.77M $0.587M $276.18M
Net change in cash -$67.83M -$108.91M $161.71M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders